TITLE

Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women

AUTHOR(S)
Sakumoto, Tetsurou; Tokunaga, Yoshimitu; Tanaka, Hideaki; Nohara, Makoto; Motegi, Emi; Shinkawa, Tadahiko; Nakaza, Aritoshi; Higashi, Masahiro
PUB. DATE
December 2010
SOURCE
Reproductive Medicine & Biology;Dec2010, Vol. 9 Issue 4, p185
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Obesity, which disturbs lipid and glucose metabolism, is a recent medical concern. It threatens human health and also has adverse effects on reproductive functions by causing insulin resistance/hyperinsulinemia, especially in women with polycystic ovary syndrome (PCOS). For PCOS patients to prevent these adverse effects, it is important to take into account improving their lifestyles by exercise and proper diets. The relationship between insulin resistance/hyperinsulinemia and reproductive disorders should be understood as fully as possible in order to provide effective treatment. It is well known that insulin resistance and compensatory hyperinsulinemia can be triggered by obesity with visceral fat accumulation. Hyperinsulinemia affects granulosa cells in small follicles and theca cells. This condition induces early response to luteinizing hormones on granulosa cells of small follicles and causes premature differentiation of these cells, which eventually results in anovulation. For improvement of anovulation because of hyperinsulinemia, insulin-sensitizing agents (biguanide and thiazolidinedione derivatives) are useful. Hyperinsulinemia may adversely affect the endometrial functions and environment, and evoke implantation disturbance. Treatment with an insulin-sensitizing agent (metformin) improves the levels of glycodelin, insulin-like growth factor binding protein 1, and blood flow in spiral arteries during the peri-implantation period. It supports endometrial function, improves the endometrial environment, and facilitates embryo implantation. The rate of early pregnancy loss during the first trimester is 30-50% in women with PCOS, which is threefold higher than for normal women. Metformin treatment improves the levels of insulin, the homeostasis model assessment for insulin resistance, and plasminogen activator inhibitor activity, and decreases early pregnancy loss. It goes without saying that lifestyle change is fundamental for improving reproductive performance in addition to treatment with insulin-sensitizing agents.
ACCESSION #
55458261

 

Related Articles

  • Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome. Valkenburg, O.; Uitterlinden, A.G.; Themmen, A.P.; de Jong, F.H.; Hofman, A.; Fauser, B.C.J.M.; Laven, J.S.E. // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2902 

    BACKGROUND Polycystic ovary syndrome (PCOS) is characterized by ovarian dysfunction. The association with obesity and insulin resistance is well established. Steroid hormones play a central role in the regulation of both ovarian function and body composition. This study aims to assess the...

  • Polycystic Ovarian Syndrome: A Complex Endocrine Disorder. Karim, Mona // Einstein Quarterly: Journal of Biology & Medicine;1998, Vol. 15 Issue 2, p92 

    Focuses on polycystic ovarian syndrome (POS), a complex endocrine disorder among women of reproductive age. Types of POS; Etiology of POS; Methods for the diagnosis of POS; Connection between insulin type II diabetes mellitus and POS; Processes related to insulin resistance; Management of POS...

  • Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. Ulloa-Aguirre, Alfredo; Portocarrero, Lesly; Zariñán, Teresa; Olivares, Aleida; Carranza-Lira, Sebastián; Veldhuis, Johannes D.; López-Alvarengas, Juan C. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2006, Vol. 12 Issue 6, p669 

    The role of hyperinsulinaemia in neuroendocrine abnormalities in polycystic ovarian syndrome (PCOS) is controversial. The present study applied frequent blood sampling to assess the response of LH to metformin treatment in insulin-resistant women with PCOS. Thirteen predominantly overweight...

  • LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea. Hendriks, Marja-Liisa; Brouwer, J.; Hompes, P. G. A.; Homburg, R.; Lambalk, C. B. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2008, Vol. 16 Issue 6, p765 

    Elevated LH is common in polycystic ovary syndrome (PCOS), but is not part of the diagnostic criteria. LH concentrations are usually assessed in the early 'follicular' phase when it is suppressed, and therefore the prevalence is underestimated. In this study. LH is measured during the 'specific...

  • Subcutaneous Adipocytes Display Normal Insulin Sensitivity. Stralfors, P. // Fertility Weekly;4/10/2006, p7 

    The article cites key research findings from Sweden indicating that evidence of insulin sensitivity is not evident in the subcutaneous adipocytes of obese hyperinsulinemic women with polycystic ovary syndrome (PCOS). PCOS is often associated with insulin resistance and the characteristics of the...

  • Clinical: Websites on polycystic ovary syndrome. Barnard, Keith // GP: General Practitioner;5/11/2007, p40 

    The article recommends several web sites on polycystic ovary syndrome (PCOS). www.vcu.edu/pcos/information.html is stated to be densely packed with information about insulin resistance in PCOS while the impact of obesity on PCOS and reproductive health is available on www.rcog.org.uk. The...

  • IR and Obesity do not Affect the Outcome of Metformin Treatment.  // Fertility Weekly;1/21/2008, p5 

    The article examines the influence of metformin on the clinical and biochemical parameters of polycystic ovary syndrome (PCOS). Chemoluminescence immunoassays were conducted to determine the levels of luteinizing hormone, follicle-stimulating hormone and insulin-like growth factor. The study...

  • POLYCYSTIC OVARY SYNDROME - CANDIDATE GENES INVOLVED IN INSULIN RESISTANCE. Gliga, Florina Ioana; Buicu, F. // Acta Medica Transilvanica;sep2012, Vol. 17 Issue 3, p256 

    Polycystic ovary syndrome (PCOS) is a complex, heterogeneous endocrinopathy, being considered the most common endocrine disorder in women reproductive period. It reflects multiple potential aetiologies and variable clinical presentations. The diagnostic criteria refer to the most pointed...

  • Relationship Between Ovarian Blood Flow and Ovulation in PCOS Women.  // Fertility Weekly;1/26/2004, p4 

    Anovulatory and ovulatory women with polycystic ovary syndrome (PCOS) experience different ovarian blood flow partly due to insulin, report researchers in Italy and the U.S. One of the characteristic features of women with PCOS is anovulation. However, 20 - 30 percent of PCOS women experience...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics